Cargando…
Blood and urinary cytokine balance and renal outcomes at cardiac surgery
BACKGROUND: Increased perioperative pro-inflammatory biomarkers, renal hypoperfusion and ischemia reperfusion injury (IRI) heighten cardiac surgery acute kidney injury (CS-AKI) risk. Increased urinary anti-inflammatory cytokines attenuate risk. We evaluated whether blood and urinary anti-inflammator...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653550/ https://www.ncbi.nlm.nih.gov/pubmed/34876054 http://dx.doi.org/10.1186/s12882-021-02621-6 |
_version_ | 1784611688606072832 |
---|---|
author | McBride, William T. Kurth, Mary Jo Domanska, Anna Watt, Joanne McLean, Gavin Joseph, Jijin Lamont, John V. Fitzgerald, Peter Ruddock, Mark W. |
author_facet | McBride, William T. Kurth, Mary Jo Domanska, Anna Watt, Joanne McLean, Gavin Joseph, Jijin Lamont, John V. Fitzgerald, Peter Ruddock, Mark W. |
author_sort | McBride, William T. |
collection | PubMed |
description | BACKGROUND: Increased perioperative pro-inflammatory biomarkers, renal hypoperfusion and ischemia reperfusion injury (IRI) heighten cardiac surgery acute kidney injury (CS-AKI) risk. Increased urinary anti-inflammatory cytokines attenuate risk. We evaluated whether blood and urinary anti-inflammatory biomarkers, when expressed as ratios with biomarkers of inflammation, hypoperfusion and IRI are increased in CS-AKI patients. METHODS: Preoperative and 24-h postoperative blood and urinary pro-inflammatory and anti-inflammatory cytokines, blood VEGF and H-FABP (hypoperfusion biomarkers), and MK, a biomarker for IRI, were measured in 401 cardiac surgery patients. Pre- and postoperative concentrations of biomarkers and selected ratios thereof, were compared between non-CS-AKI and CS-AKI patients. RESULTS: Compared with non-CS-AKI, blood pro-inflammatory (pre- and post-op TNFα, IP-10, IL-12p40, MIP-1α, NGAL; pre-op IL-6; post-op IL-8, MK) and anti-inflammatory (pre- and post-op sTNFsr1, sTNFsr2, IL-1RA) biomarkers together with urinary pro-inflammatory (pre- and post-op uIL-12p40; post-op uIP-10, uNGAL) and anti-inflammatory (pre- and post-op usTNFsr1, usTNFsr2, uIL-1RA) biomarkers, were significantly higher in CS-AKI patients. Urinary anti-inflammatory biomarkers, when expressed as ratios with biomarkers of inflammation (blood and urine), hypoperfusion (blood H-FABP and VEGF) and IRI (blood MK) were decreased in CS-AKI. In contrast, blood anti-inflammatory biomarkers expressed as similar ratios with blood biomarkers were increased in CS-AKI. CONCLUSIONS: The urinary anti-inflammatory response may protect against the injurious effects of perioperative inflammation, hypoperfusion and IRI. These finding may have clinical utility in bioprediction and earlier diagnosis of CS-AKI and informing future therapeutic strategies for CS-AKI patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02621-6. |
format | Online Article Text |
id | pubmed-8653550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86535502021-12-08 Blood and urinary cytokine balance and renal outcomes at cardiac surgery McBride, William T. Kurth, Mary Jo Domanska, Anna Watt, Joanne McLean, Gavin Joseph, Jijin Lamont, John V. Fitzgerald, Peter Ruddock, Mark W. BMC Nephrol Research BACKGROUND: Increased perioperative pro-inflammatory biomarkers, renal hypoperfusion and ischemia reperfusion injury (IRI) heighten cardiac surgery acute kidney injury (CS-AKI) risk. Increased urinary anti-inflammatory cytokines attenuate risk. We evaluated whether blood and urinary anti-inflammatory biomarkers, when expressed as ratios with biomarkers of inflammation, hypoperfusion and IRI are increased in CS-AKI patients. METHODS: Preoperative and 24-h postoperative blood and urinary pro-inflammatory and anti-inflammatory cytokines, blood VEGF and H-FABP (hypoperfusion biomarkers), and MK, a biomarker for IRI, were measured in 401 cardiac surgery patients. Pre- and postoperative concentrations of biomarkers and selected ratios thereof, were compared between non-CS-AKI and CS-AKI patients. RESULTS: Compared with non-CS-AKI, blood pro-inflammatory (pre- and post-op TNFα, IP-10, IL-12p40, MIP-1α, NGAL; pre-op IL-6; post-op IL-8, MK) and anti-inflammatory (pre- and post-op sTNFsr1, sTNFsr2, IL-1RA) biomarkers together with urinary pro-inflammatory (pre- and post-op uIL-12p40; post-op uIP-10, uNGAL) and anti-inflammatory (pre- and post-op usTNFsr1, usTNFsr2, uIL-1RA) biomarkers, were significantly higher in CS-AKI patients. Urinary anti-inflammatory biomarkers, when expressed as ratios with biomarkers of inflammation (blood and urine), hypoperfusion (blood H-FABP and VEGF) and IRI (blood MK) were decreased in CS-AKI. In contrast, blood anti-inflammatory biomarkers expressed as similar ratios with blood biomarkers were increased in CS-AKI. CONCLUSIONS: The urinary anti-inflammatory response may protect against the injurious effects of perioperative inflammation, hypoperfusion and IRI. These finding may have clinical utility in bioprediction and earlier diagnosis of CS-AKI and informing future therapeutic strategies for CS-AKI patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02621-6. BioMed Central 2021-12-08 /pmc/articles/PMC8653550/ /pubmed/34876054 http://dx.doi.org/10.1186/s12882-021-02621-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research McBride, William T. Kurth, Mary Jo Domanska, Anna Watt, Joanne McLean, Gavin Joseph, Jijin Lamont, John V. Fitzgerald, Peter Ruddock, Mark W. Blood and urinary cytokine balance and renal outcomes at cardiac surgery |
title | Blood and urinary cytokine balance and renal outcomes at cardiac surgery |
title_full | Blood and urinary cytokine balance and renal outcomes at cardiac surgery |
title_fullStr | Blood and urinary cytokine balance and renal outcomes at cardiac surgery |
title_full_unstemmed | Blood and urinary cytokine balance and renal outcomes at cardiac surgery |
title_short | Blood and urinary cytokine balance and renal outcomes at cardiac surgery |
title_sort | blood and urinary cytokine balance and renal outcomes at cardiac surgery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653550/ https://www.ncbi.nlm.nih.gov/pubmed/34876054 http://dx.doi.org/10.1186/s12882-021-02621-6 |
work_keys_str_mv | AT mcbridewilliamt bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT kurthmaryjo bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT domanskaanna bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT wattjoanne bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT mcleangavin bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT josephjijin bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT lamontjohnv bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT fitzgeraldpeter bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery AT ruddockmarkw bloodandurinarycytokinebalanceandrenaloutcomesatcardiacsurgery |